NSE · Healthcare · Drug Manufacturers - General
EPS came in at 6.60 against a street estimate of 5.81 — a beat of 13.6%.
with an average price target of ₹1,620.00.
| Document | Date |
|---|---|
| Annual report FY2026 SENORES PHARMACEUTICALS LIMITED - ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Market Capitalization (as of March 31, 2026): ₹3,490.40 Crores • | 2026-09-03 |
| Q1 FY27 earnings call SENORES PHARMACEUTICALS LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Consolidated revenue from operations: INR 180 crores (Q1 FY27), up 36% Y-o-Y • | 2026-08-03 |
| Investor presentation SENORES PHARMACEUTICALS LIMITED – Q1 FY27 INVESTOR SUMMARY --- HEADLINE NUMBERS • Revenue Q1FY27: ₹180.2 Crs, up 36% Y-o-Y (Q1FY26: ₹132.6 Crs) • | 2026-07-27 |
| Q4 FY26 earnings call SENORES PHARMACEUTICALS LIMITED – Q4 FY26 SUMMARY --- HEADLINE NUMBERS • FY26 Total Revenue: INR 664 crores (62% Y-o-Y growth vs FY25) • FY26 Profi | 2026-05-19 |
| Investor presentation · Q4 FY26 SENORES PHARMACEUTICALS LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Total Income FY26: Rs. 664.0 crores, up 61.8% year-on-year (Q4FY26: Rs. 189.7 | 2026-05-14 |
| Quarterly results · Q4 FY26 SENORES PHARMACEUTICALS LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q4 FY26 Total Income: Rs. 190 Cr (+66% Y-o-Y) • Q4 FY26 EBITDA: Rs. 62 Cr (+2 | 2026-05-14 |
| Q3 FY26 earnings call SENORES PHARMACEUTICALS LIMITED – Q3FY26 SUMMARY HEADLINE NUMBERS • Q3FY26 consolidated revenue: INR175 crores (64% YoY growth) • 9MFY26 consolidate | 2026-01-27 |
| Investor presentation · Q3 FY26 SENORES PHARMACEUTICALS LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Total Income Q3FY26: Rs. 174.6 crores (up 64% Y-o-Y from Rs. 106.4 crores) • T | 2026-01-20 |
Readable in the app.
| Announcement | Date |
|---|---|
| Company informed about acquisition updates Senores Pharmaceuticals Limited has informed the Exchange regarding updates on acquisition | 2026-01-16 |
| Acquisition of another business or entity completed Senores Pharmaceuticals Limited has informed the Exchange regarding Acquisition | 2025-12-15 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SENORES PHARMACEUTICALS L — free to start.
Google PlayApp StoreData updated 2026-09-18.